Yuflyma Adalimumab

Yuflyma is a high-concentration, citrate-free biosimilar of Humira (adalimumab), used to treat various inflammatory conditions such as rheumatoid arthritis, crohn's disease, and psoriasis. The product shown is a subcutaneous injection solution packaged in a pre-filled pen.

The brand was developed and is manufactured by Celltrion, a major South Korean biopharmaceutical company known for its extensive portfolio of biosimilars. Celltrion manages the end-to-end production process at its high-tech facilities in South Korea. The product is distributed globally, often through Celltrion Healthcare, which handles the international marketing and supply chain logistics for the brand's expansive medical portfolio.